BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/20/2025 8:38:51 AM | Browse: 170 | Download: 635
 |
Received |
|
2024-09-09 06:07 |
|
Peer-Review Started |
|
2024-09-10 06:19 |
|
First Decision by Editorial Office Director |
|
2024-10-20 11:28 |
|
Return for Revision |
|
2024-10-20 11:28 |
|
Revised |
|
2024-11-13 17:13 |
|
Publication Fee Transferred |
|
2024-11-17 08:39 |
|
Second Decision by Editor |
|
2024-12-23 02:41 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-12-23 09:34 |
|
Articles in Press |
|
2024-12-23 09:34 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-01-15 01:47 |
|
Publish the Manuscript Online |
|
2025-02-20 08:38 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Strategies for discovering novel hepatocellular carcinoma biomarkers
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shi-Tao Wu, Li Zhu, Xiao-Ling Feng, Hao-Yu Wang and Fang Li |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Fang Li, MD, PhD, Professor, Department of General Surgery, Chongqing General Hospital, No. 118 Xingguang Avenue, Liangjiang New District, Chongqing 401147, China. leef123456@163.com |
| Key Words |
Hepatocellular carcinoma; Biomarkers; Multi-omics; Early detection; Liver cancer |
| Core Tip |
This review provides a comprehensive analysis of current and emerging biomarkers for hepatocellular carcinoma, emphasizing the significance of multi-omics approaches in enhancing diagnostic accuracy and treatment strategies. It highlights the challenges in biomarker discovery, including pre-analytical, analytical, and post-analytical factors, and underscores the need for large-scale validation and cross-disciplinary collaboration. The insights presented aim to advance early detection, improve patient outcomes, and pave the way for personalized treatment approaches in liver cancer management. |
| Publish Date |
2025-02-20 08:38 |
| Citation |
Wu ST, Zhu L, Feng XL, Wang HY, Li F. Strategies for discovering novel hepatocellular carcinoma biomarkers. World J Hepatol 2025; 17(2): 101201 |
| URL |
https://www.wjgnet.com/1948-5182/full/v17/i2/101201.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v17.i2.101201 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
